Neuronetics (STIM) Tops Q2 EPS by 18c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. VRNS
2. CRWV
3. JBHT
4. TSLA
5. SCHW
6. GPRK
7. TRV
8. TFC
9. AA
10. TECHM:IN

Go back to Neuronetics (STIM) Tops Q2 EPS by 18c

Neuronetics Reports Record Second Quarter 2023 Financial and Operating Results

August 8, 2023 7:30 AM EDT

MALVERN, Pa., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the Company or Neuronetics) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help with the best neurohealth therapies in the world, today announced its financial and operating results for the second quarter of 2023.

Second Quarter 2023 Highlights

Second quarter 2023 revenue of $17.6 million, an increase of 8% over the second quarter of 2022U.S. treatment session revenue increased 9% over the second quarter of 2022Shipped 54... More